A parasitic fly that once devastated herds across the Southwest is reportedly back at the Texas line, and a Dallas startup says a single gene tweak could stop it. Colossal Biosciences, better known for headline-grabbing de-extinction projects, is turning its gene-editing toolbox on the New World screwworm as ranchers brace for a familiar threat.
The company’s pitch comes as officials track the pest’s movement north from a long-standing barrier in Panama. The screwworm, Cochliomyia hominivorax, infests open wounds in livestock and wildlife, causing severe tissue damage and fast-moving losses. Colossal argues that a targeted edit in the insect could short-circuit reproduction and break transmission. The idea is bold. The stakes are high for cattle, deer, and the rural economies that rely on them.
As the New World screwworm crosses back into Texas, Colossal Biosciences is betting that a single gene edit can end the fight.
A Parasite With a Costly History
The U.S. and Mexico spent decades pushing the screwworm south using sterile insect releases, an approach that won the day in the 20th century. By flooding the field with sterile males, the fly’s population crashed. The U.S. declared eradication in 1966, extended it to Mexico by 1991, and held the line in Panama with a permanent program.
Before eradication, the screwworm was notorious on ranches. Calves could die within days if untreated. Economic studies from the period estimated losses in the tens of millions of dollars each year in the U.S. alone, not counting treatment and labor. The risk never disappeared, though. A 2016 outbreak in the Florida Keys killed endangered Key deer and forced an emergency response led by sterile releases and strict animal checks.
Today, the barrier program still air-drops sterile flies from Central America to block reinvasion. But sustained pressure from the south and occasional jumps via animal movement keep the threat alive. That is the context for private-sector interest in fresh tools.
What the Company Proposes
Colossal’s claim centers on a single edit that would disrupt the screwworm’s ability to reproduce or develop. While the firm has not publicly detailed the exact mechanism, the pitch implies a heritable change that, once introduced, could reduce populations with fewer releases than current methods.
The attraction is clear. A one-time or low-frequency release, if it works as designed, could be cheaper and easier than constant sterile fly production. It could also reach wild populations that are hard to saturate with conventional releases in rough terrain or during peak seasons.
Yet the science carries real-world hurdles. Editing the right sequence, achieving stable inheritance in the wild, and avoiding unintended effects on non-target species are major tests. Regulators would also need to evaluate environmental impact and cross-border use, since the screwworm’s range spans the Americas.
Benefits and Risks Under Review
Veterinary and wildlife groups often back aggressive action against screwworms because of the animal welfare toll. At the same time, they stress measured steps. Decades of sterile-insect work offer a baseline of safety and predictability that any new tool must match or beat.
Advocates for gene-based controls argue that precision edits can target only the pest, avoiding chemicals and reducing repeated flights. Skeptics warn that once an edit is in the wild, recall is not simple. They also question whether a single change is enough against an insect that can adapt fast.
- Cost: Could one edit cut program costs more than sterile releases?
- Speed: Will it act fast enough during an outbreak?
- Safety: How are non-target impacts ruled out?
- Governance: Who decides release steps across borders?
Lessons From Past Outbreaks
Florida’s 2016 episode offers a case study. The response relied on tried-and-true tools: quarantine, veterinary checks, and massive sterile releases. The outbreak ended, but only after months of work and significant expense. That experience fuels interest in options that can move faster and reach isolated hosts, such as feral hogs or wild deer on large ranches.
If Texas sees a similar incursion, ranchers and wildlife managers will likely push for a rapid blend of surveillance, wound care protocols, and sterile releases. A gene-edit trial would have to fit within that emergency playbook, not replace it on day one.
What Happens Next
Any gene-based strategy would require phased testing under federal and state oversight, starting in the lab, then field cages, then controlled pilots, likely outside the U.S. until approvals are in place. Cross-border coordination with Central American partners would be essential, as the current barrier program is international by design.
For now, Colossal’s line is clear and ambitious. The company says a single edit can finish a job that has demanded planes, factories, and years of vigilance. Ranchers will welcome any safe edge they can get. Regulators will ask for data. The screwworm, true to form, will not make it easy.
The coming months will show whether Texas faces sporadic cases or a broader push north. Watch for alerts from state animal health officials, any pilot studies announced by the company, and signals from the long-running sterile release program. If the pest gains ground, pressure to test new tools will rise. If it stalls, the gene-edit pitch will still be waiting at the fenceline.
